Sepsis subtyping with precision medicine
16 Jan 2025
Sepsis in patients can present differently, which means it needs to be treated differently. Dr. Ephraim L. Tsalik explores the variability of sepsis and how clinicians can now view sepsis as a collection of distinct subtypes, each needing its own specialized treatment. The monocyte distribution width (MDW), is a biomarker that can help to diagnose the severity of infection and risk of sepsis. The MCV is easily accessible and can be included in the routine complete blood count (CBC) test to aid clinicians in decision making with no additional time requirements. Learn how the Danaher Beacon program is supporting test development to formulate sepsis into two subtypes. From this, immunomodulatory therapy can be used to progress towards precision medicine for treating sepsis.
About the company
Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.
